LCS
TDOC icon

Levin Capital Strategies’s Teladoc Health TDOC Stock Holding History

Levin Capital Strategies’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,000
Closed -$81.8K – 291
2026
Q1 		$81.8K Buy
+15,000
New +$84.2K 0.01% 222
2018
Q2 		– Sell
-10,000
Closed -$403K – 330
2018
Q1 		$403K Buy
+10,000
New +$377K 0.01% 208

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Levin Capital Strategies's TDOC Position: Q2 2026 in Review

Levin Capital Strategies sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 15,000 shares — an estimated $81.8K sold.

Levin Capital Strategies first reported a position in TDOC in Q1 2018 and held it in 2 quarters. The position peaked at $403K in Q1 2018. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Levin Capital Strategies reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Levin Capital Strategies sold 15,000 Teladoc Health shares in Q2 2026, an estimated $81.8K.
  • Levin Capital Strategies first reported a position in Teladoc Health in Q1 2018 and held it in 2 quarters.
  • Levin Capital Strategies's Teladoc Health position peaked at $403K in Q1 2018.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.